Forbion Elevates Mathias Vinther to Partner After Diligent Biotech Leadership

Forbion’s Growth Fund has promoted Mathias Vinther to partner, reflecting his diligence in due diligence and portfolio management since joining in 2022. His new role involves broader investment decisions and strategic leadership in biotech investing.

Vinther first arrived at Forbion in March 2022 as a principal, leading due diligence on growth-stage biotech opportunities across Europe and the US. His efforts have supported successful exits and initial public offerings for the fund, demonstrating his commitment to portfolio growth and regulatory strategy.

He has actively guided portfolio companies like Navigator, Vectiv Bio, and Capstan, focusing on business growth and regulatory strategy. Now, as partner, he will take on a larger role in shaping the Growth Fund’s direction and expanding Forbion’s scientific and industry connections.

Beyond investment decisions, Vinther will help steer portfolio companies and expand Forbion’s influence in biotech investing. His promotion reflects his contributions to the fund’s performance over the past two years, strengthening Forbion’s leadership in this sector. His expanded responsibilities begin immediately.